CONTROL OF EYELID RETRACTION ASSOCIATED WITH GRAVES-DISEASE WITH BOTULINUM-A TOXIN

被引：0
|
作者：
BIGLAN, AW
机构：
[1] UNIV PITTSBURGH,SCH MED,DEPT OPHTHALMOL,PITTSBURGH,PA 15261
[2] EYE & EAR INST PITTSBURGH,PITTSBURGH,PA
来源：
OPHTHALMIC SURGERY AND LASERS | 1994年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Two patients had satisfactory control of eyelid retraction associated with thyroid orbitopathy with repeated treatment of the levator palpebrae superioris muscle with botulinum A toxin. The effects of the toxin lasted for 3 to 4 months.
引用
收藏
页码：186 / 188
页数：3
相关论文
共 50 条
  • [21] LEVATOR-PALPEBRAE-SUPERIORIS MUSCLE - MR EVALUATION OF ENLARGEMENT AS A CAUSE OF UPPER EYELID RETRACTION IN GRAVES-DISEASE
    OHNISHI, T
    NOGUCHI, S
    MURAKAMI, N
    NAKAHARA, H
    HOSHI, H
    JINNOUCHI, S
    FUTAMI, S
    NAGAMACHI, S
    WATANABE, K
    RADIOLOGY, 1993, 188 (01) : 115 - 118
  • [22] BOTULINUM TOXIN TYPE-A IN UPPER LID RETRACTION OF GRAVES OPHTHALMOPATHY
    EBNER, R
    JOURNAL OF CLINICAL NEURO-OPHTHALMOLOGY, 1993, 13 (04): : 258 - 261
  • [23] A CASE OF GRAVES-DISEASE ASSOCIATED WITH POLYMYOSITIS
    SAKATA, S
    FUWA, Y
    GOSHIMA, E
    NAKAMURA, S
    YAMAKITA, N
    MAEDA, M
    MIURA, K
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1989, 12 (11) : 837 - 840
  • [24] MEMBRANOUS GLOMERULONEPHRITIS ASSOCIATED WITH GRAVES-DISEASE
    OLAIZOLA, MY
    AIKAWA, M
    BARNETT, E
    ECKEL, RE
    POST, RS
    LABORATORY INVESTIGATION, 1979, 40 (02) : 276 - 277
  • [25] Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction
    Bastos É.M.
    Silva R.D.P.
    European Journal of Plastic Surgery, 2012, 35 (4) : 317 - 319
  • [26] Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A
    Castaneda, A. Nava
    Canales, J. L. Tovilla
    Hayashi, L. Garnica
    Velasco y Levy, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (04): : 279 - 284
  • [27] Synergistic Therapy for Graves' Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a Combination
    Kim, Yuri
    Lew, Helen
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [28] GRAVES-DISEASE ASSOCIATED WITH HISTOLOGIC HASHIMOTOS THYROIDITIS
    FALK, SA
    BIRKEN, EA
    RONQUILLO, AH
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1985, 93 (01) : 86 - 91
  • [29] Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction
    Wabbels, B.
    Foerl, M.
    OPHTHALMOLOGE, 2007, 104 (09): : 771 - 776
  • [30] SQUAMOUS-CELL CARCINOMA OF THE EYELID MASQUERADING AS MALIGNANT OPHTHALMOPATHY OF GRAVES-DISEASE
    FORD, HC
    DELAHUNT, JW
    TEAGUE, CA
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1983, 67 (09) : 596 - 599
12345